Get Started

CRBU

NASD Caribou Biosciences, Inc.
Nov 4, 2026 · 8:38 AM ET LAST TRADE Market Closed

$0.4594 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.4594

YTD change
-71.11%
vs 20-day SMA
-5.77%
vs 200-day SMA
-71.63%

Price ranges

Previous day
$0.4150 $0.4650
open $0.4160 close $0.4594
+$0.0434 (+10.43%)
Today
$0.0000 $0.0000
$0.4594
Past week
$0.4100 $0.4995
from $0.4607 now $0.4594
-$0.0013 (-0.28%)
Past month
$0.4100 $1.1350
from $1.1350 now $0.4594
-$0.6756 (-59.52%)
This year
$0.4100 $2.4900
from $1.5900 now $0.4594
-$1.1306 (-71.11%)

Price & Performance

-1.45 (-75.95%) / 6M

$0.2627$1.04$1.81$2.59May 4Aug 4Nov 3

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 98.6% away from all-time highs of $32.6450
  • CRBU is down 71% since the beginning of the year
  • CRBU is down 79% over the past 12 months
  • CRBU is down 60% over the past 1 month
  • 13% of all CRBU investors are betting against CRBU

CRBU reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -78.8%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.24
Earnings momentum +8.4% Quarterly EPS growth
Quarterly change +8.4%

Valuation

P/E ratio N/A
Enterprise value $-39266200.0
Beta 3.17

Balance sheet & scale

IncomeN/A
Revenue$10.0M
Cash$112.3M
Debt$26.7K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $49.3M

Caribou Biosciences, Inc. engages in the development of an internal pipeline of off-the-shelf CAR-T and CAR-NK cell therapies. Its tools and technologies provide transformative capabilities to basic and applied biological research, therapeutic development, agricultural biotechnology, and industrial biotechnology. The company was founded by Jennifer A. Doudna, Rachel E. Haurwitz, Martin Jinek and James Berger on October 28, 2011 and is headquartered in Berkeley, CA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $461.26 -0.90%
MRNA Moderna, Inc. $228.44 +3.45%
RVMD Revolution Medicines, Inc. $194.23 +3.22%
ROIV Roivant Sciences Ltd. $36.04 +0.42%
BNTX BioNTech SE Sponsored ADR $86.92 -0.70%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.